• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冬凌草甲素与丙戊酸联合对 HL-60 白血病细胞的协同抗肿瘤作用。

Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells.

机构信息

Department of hematology, Hunan Province People's Hospital, Changsha, Hunan, China.

出版信息

J Cell Biochem. 2019 Apr;120(4):5620-5627. doi: 10.1002/jcb.27845. Epub 2018 Oct 15.

DOI:10.1002/jcb.27845
PMID:30320906
Abstract

BACKGROUND

Oridonin is a diterpenoid isolated from Rabdosia rubescens with potent anticancer activities. Valproic acid (VPA) is a recently emerged antineoplastic histone deacetylase inhibitor. The aim of the present study is to investigate the synergistic role of oridonin and VPA to inhibit the growth and metastasis of human leukemia cells.

METHODS

The effect of oridonin and VPA on proliferation was evaluated by the MTT assay. Cell migration and invasion were evaluated by transwell and scratch assays, respectively. In addition, cell apoptosis was examined by flow cytometry. The inhibitive effects of oridonin and VPA in vivo were determined by using xenografted nude mice.

RESULTS

The results demonstrated that oridonin in combination with VPA synergistically inhibited the proliferation of HL-60 cells, and induced obvious caspase-dependent apoptosis through activation of the intrinsic apoptosis pathway, which is involved in the downregulation of Bcl-2/Bax ratio. Furthermore, the combination treatment in vivo remarkably reduced the xenograft tumor size and triggered tumor cell apoptosis.

CONCLUSION

Our results suggested that the novel combination of oridonin plus VPA exerted synergistic antiproliferative and apoptosis-inducing effects on human myeloid leukemia cells, and may serve as a potentially promising antileukemia strategy.

摘要

背景

冬凌草甲素是一种从冬凌草中分离出来的二萜类化合物,具有很强的抗癌活性。丙戊酸(VPA)是一种新兴的抗肿瘤组蛋白去乙酰化酶抑制剂。本研究旨在探讨冬凌草甲素与 VPA 联合抑制人白血病细胞生长和转移的协同作用。

方法

通过 MTT 法评估冬凌草甲素和 VPA 对增殖的影响。通过 Transwell 和划痕实验分别评估细胞迁移和侵袭。此外,通过流式细胞术检测细胞凋亡。通过使用异种移植裸鼠来确定冬凌草甲素和 VPA 的体内抑制作用。

结果

结果表明,冬凌草甲素与 VPA 联合可协同抑制 HL-60 细胞的增殖,并通过激活内在凋亡途径诱导明显的 caspase 依赖性凋亡,这涉及到 Bcl-2/Bax 比值的下调。此外,体内联合治疗显著减小了异种移植肿瘤的大小并触发了肿瘤细胞凋亡。

结论

我们的结果表明,冬凌草甲素加 VPA 的新组合对人髓样白血病细胞具有协同的增殖抑制和诱导凋亡作用,可能是一种有前途的抗白血病策略。

相似文献

1
Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells.冬凌草甲素与丙戊酸联合对 HL-60 白血病细胞的协同抗肿瘤作用。
J Cell Biochem. 2019 Apr;120(4):5620-5627. doi: 10.1002/jcb.27845. Epub 2018 Oct 15.
2
A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.冬凌草甲素与丙戊酸联合应用增强HL-60白血病细胞凋亡诱导作用的新研究
Int J Oncol. 2016 Feb;48(2):734-46. doi: 10.3892/ijo.2015.3294. Epub 2015 Dec 15.
3
Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.冬凌草甲素通过线粒体途径诱导胆囊癌细胞凋亡和细胞周期停滞。
BMC Cancer. 2014 Mar 21;14:217. doi: 10.1186/1471-2407-14-217.
4
Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.冬凌草甲素通过激活 PPAR-γ 抑制 Nrf2 通路发挥对骨肉瘤的抗癌作用。
Cell Death Dis. 2018 Jan 11;9(1):15. doi: 10.1038/s41419-017-0031-6.
5
Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.冬凌草甲素通过线粒体途径诱导人胃癌SGC - 7901细胞凋亡。
Int J Oncol. 2016 Jun;48(6):2453-60. doi: 10.3892/ijo.2016.3479. Epub 2016 Apr 7.
6
Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells.冬凌草甲素通过诱导细胞凋亡和抑制人急性髓性白血病细胞中基质金属蛋白酶(MMP)的表达,有效逆转顺铂耐药性。
Saudi J Biol Sci. 2017 Mar;24(3):678-686. doi: 10.1016/j.sjbs.2017.01.042. Epub 2017 Jan 25.
7
Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.冬凌草甲素可诱导结肠癌细胞凋亡,而抑制微小RNA-32的表达可增强冬凌草甲素介导的凋亡作用。
Biomed Pharmacother. 2015 May;72:125-34. doi: 10.1016/j.biopha.2015.04.016. Epub 2015 Apr 27.
8
Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.冬凌草甲素通过抑制 miR-17 和 miR-20a 来触发细胞凋亡,并通过去抑制 BIM-S 来逆转化疗耐药性。
Cancer Res. 2014 Aug 15;74(16):4409-19. doi: 10.1158/0008-5472.CAN-13-1748. Epub 2014 May 28.
9
Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.冬凌草甲素诱导高转移性人乳腺癌细胞凋亡,抑制迁移和侵袭。
Am J Chin Med. 2013;41(1):177-96. doi: 10.1142/S0192415X13500134.
10
Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.冬凌草甲素通过抑制 PI3K/AKT/mTOR 和 Ras/Raf 通路诱导食管癌细胞线粒体依赖性凋亡。
J Cell Biochem. 2019 Mar;120(3):3736-3746. doi: 10.1002/jcb.27654. Epub 2018 Sep 19.

引用本文的文献

1
Isodon rubescens research literature based on Web of Science database for visual analysis: A review.基于Web of Science数据库的冬凌草研究文献可视化分析:综述
Medicine (Baltimore). 2025 May 2;104(18):e41945. doi: 10.1097/MD.0000000000041945.
2
Oridonin from : An emerging potential in cancer therapy - A comprehensive review.冬凌草甲素的研究进展:癌症治疗中的新兴潜力——综述
Food Sci Nutr. 2024 Feb 1;12(5):3046-3067. doi: 10.1002/fsn3.3986. eCollection 2024 May.
3
Research and Development Progression of Oridonin for Hematological Malignancies Therapy.
冬凌草甲素用于血液系统恶性肿瘤治疗的研发进展
Curr Med Chem. 2025;32(23):4713-4724. doi: 10.2174/0109298673273034231215190811.
4
A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid.丙戊酸的药理学应用及药物诱导毒性的综合综述。
Saudi Pharm J. 2023 Feb;31(2):265-278. doi: 10.1016/j.jsps.2022.12.001. Epub 2022 Dec 9.
5
Recent advances in oridonin derivatives with anticancer activity.具有抗癌活性的冬凌草甲素衍生物的最新进展
Front Chem. 2023 Feb 9;11:1066280. doi: 10.3389/fchem.2023.1066280. eCollection 2023.
6
From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer.从组蛋白去乙酰化酶到电压门控离子通道:接下来是什么?抗癫痫药物在癌症中重新定位的漫长之路。
Cancers (Basel). 2022 Sep 10;14(18):4401. doi: 10.3390/cancers14184401.
7
Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.冬凌草甲素通过下调 JAK2/STAT3 信号通路抑制甲状腺癌细胞的上皮间质转化和血管生成。
Int J Med Sci. 2022 May 27;19(6):965-974. doi: 10.7150/ijms.70733. eCollection 2022.
8
Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.冬凌草甲素:药理学、药代动力学及毒性综述
Front Pharmacol. 2021 Jul 5;12:645824. doi: 10.3389/fphar.2021.645824. eCollection 2021.
9
Influence of verapamil on the pharmacokinetics of oridonin in rats.维拉帕米对大鼠体内冬凌草甲素药代动力学的影响。
Pharm Biol. 2019 Dec;57(1):787-791. doi: 10.1080/13880209.2019.1688844.